New study reveals self-replicating RNA and novel vaccine delivery technology demonstrate enhanced safety and efficacy

As the world continues to combat various infectious diseases, the development of novel vaccine technologies remains at the forefront of scientific research. mRNA-based vaccines and utilization of lipid nanoparticles (LNPs) for their delivery, have recently shown encouraging results in diseases such as COVID-19.